Drugs News and Research

RSS

Study pinpoints two proteins that sense blood pressure and help control baroreceptor reflex

The baroreceptor reflex is a fascinating medical phenomenon. The reflex is controlled by specialized neurons that react in just a fraction of a second to keep blood pressure fairly consistent.

30 Oct 2018

Using genome editing to prevent sudden cardiac death

Each year, at least 3 million people worldwide die of sudden cardiac death. In the U.S., this number reaches up to 450,000 people.

30 Oct 2018

Meta-analysis reveals effective treatment options for urticarial vasculitis

What treatments are available for patients with the rare inflammatory disease known as urticarial vasculitis? How effective are these treatments? Researchers from Charité - Universitätsmedizin Berlin embarked on a systematic review and meta-analysis to address these questions.

30 Oct 2018

Dopamine neurons play role in reinforcing addictive effects of heroin

Scientists have made a major advance in untangling the brain circuits that lead to the powerful addictive effects of heroin, a study in the open-access journal eLife reports.

30 Oct 2018

New City of Hope CAR T cell trial focuses on HER2-positive breast cancer patients with brain metastases

Women with HER2-positive breast cancer that has spread to the brain need more treatment options, and City of Hope and Mustang Bio Inc. are meeting that challenge.

30 Oct 2018

With one hand, administration boosts ACA marketplaces, weakens them with another

In the span of less than 12 hours this week, the Trump administration took two seemingly contradictory actions that could have profound effects on the insurance marketplaces set up by the Affordable Care Act.

30 Oct 2018

Cryo-electron microscopy helps study proteins responsible for amyloid-based diseases

The century old mission to understand how the proteins responsible for amyloid-based diseases such as Alzheimer's, Huntingdon's and Parkinson's work has taken major steps forward in the last 12 months, thanks to a revolution in a powerful microscopy technique used by scientists.

30 Oct 2018

LSD changes the communication patterns between the brain regions, shows study

LSD changes the communication patterns between regions of the brain, a new study by researchers of the University of Zurich and Yale University shows.

30 Oct 2018

PrEP shown to be safe and effective for widespread use

New research presented at the HIV Drug Therapy Conference in Glasgow today shows that pre-exposure prophylaxis could be given to millions of people worldwide with no increased risk of safety issues during treatment.

30 Oct 2018

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Nanoparticles that could reprogram a cancer patient's immune system inside their own body. Understanding a mysterious type of brain cell in the hopes of shedding new light on Alzheimer's disease. Reimagining nuclei, the DNA-storage compartments of our cells, as miniature lava lamps.

30 Oct 2018

Promising potential of stimuli-responsive nanomaterial for cancer therapy

Nanosystems that deliver anticancer drugs or imaging materials to tumors are showing significant progress, particularly those that respond to tumor-related stimuli, according to a review published in the journal Science and Technology of Advanced Materials.

30 Oct 2018

Aggressive local therapy for stage IV lung cancer patients improves progression-free survival

Adding radiation therapy or surgery to systemic therapy for stage IV lung cancer patients whose cancer has spread to a limited number of sites can extend overall survival time significantly, according to new results from a multicenter, randomized, controlled phase II study. The findings were presented last week at the 60th Annual Meeting of the American Society for Radiation Oncology

30 Oct 2018

Cellix Bio announces completion of Pre-IND meeting with FDA on novel prodrug of mesalamine for ulcerative colitis

Cellix Biosciences Inc., a development-stage pharmaceutical company, today announced successful completion of a Pre-Investigational New Drug meeting with the U.S. Food and Drug Administration for the development of CLX-103, a novel molecular conjugate of mesalamine for the treatment of mild to moderate ulcerative colitis.

30 Oct 2018

Scientists discover cell adhesion mechanism used by mycoplasma genitalium

Researchers from the Molecular Biology Institute of Barcelona and the Institute of Biotechnology and Biomedicine have discovered the mechanism by which the bacterium Mycoplasma genitalium) adheres to human cells.

29 Oct 2018

Researchers uncover new insights on cancer growth

Walter and Eliza Hall Institute researchers have uncovered new insights into how the normal controls on cell growth are lost in cancer cells, leading to rapid tumor expansion.

29 Oct 2018

Investigational drug targeting the opioid system may help reduce symptoms of major depression

Two clinical trials of an investigational drug that targets the opioid system support its safety and effectiveness in reducing symptoms of major depression, when added to standard antidepressant treatment.

29 Oct 2018

Neuroene Therapeutics receives $1.5 million NIH grant to develop anti-seizure compound for epilepsy

Neuroene Therapeutics, a start-up company founded by mitochondrial biologist Sherine S. L. Chan, Ph.D. and medicinal chemist C. James Chou, Ph.D. of the Medical University of South Carolina, has received a $1.5 million NIH Phase II Small Business Innovation Research grant to optimize vitamin K analogues that could improve seizure control in patients with drug-resistant epilepsy.

29 Oct 2018

Hormone injections reduce risk for early menopause from breast cancer chemotherapy

Final results of SWOG Cancer Research Network's groundbreaking international Prevention of Early Menopause Study clinical trial are in, and they show continued evidence that women who get injections of the hormone drug goserelin along with standard breast cancer chemotherapy are more likely to become pregnant - without developing negative side effects or shortening their lives.

29 Oct 2018

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

29 Oct 2018

Experimental vaccine shows promise to protect stroke survivors from blood clots

A vaccine may one day be able to replace oral blood thinners to reduce the risk of secondary strokes caused by blood clots, without increasing the risk of serious bleeding or triggering an autoimmune response, according to new research in the American Heart Association's journal Hypertension.

29 Oct 2018

Drugs News and Research

Study pinpoints two proteins that sense blood pressure and help control baroreceptor reflex

Using genome editing to prevent sudden cardiac death

Meta-analysis reveals effective treatment options for urticarial vasculitis

Dopamine neurons play role in reinforcing addictive effects of heroin

New City of Hope CAR T cell trial focuses on HER2-positive breast cancer patients with brain metastases

With one hand, administration boosts ACA marketplaces, weakens them with another

Cryo-electron microscopy helps study proteins responsible for amyloid-based diseases

LSD changes the communication patterns between the brain regions, shows study

PrEP shown to be safe and effective for widespread use

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Promising potential of stimuli-responsive nanomaterial for cancer therapy

Aggressive local therapy for stage IV lung cancer patients improves progression-free survival

Cellix Bio announces completion of Pre-IND meeting with FDA on novel prodrug of mesalamine for ulcerative colitis

Scientists discover cell adhesion mechanism used by mycoplasma genitalium

Researchers uncover new insights on cancer growth

Investigational drug targeting the opioid system may help reduce symptoms of major depression

Neuroene Therapeutics receives $1.5 million NIH grant to develop anti-seizure compound for epilepsy

Hormone injections reduce risk for early menopause from breast cancer chemotherapy

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

Experimental vaccine shows promise to protect stroke survivors from blood clots

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News